OBJECTIVES: To characterize the individual and combined effects of multimorbidity and functional limitation on healthcare use and mortality in a large, community cohort of individuals with heart failure (HF). DESIGN: Prospective cohort study. SETTING: Eleven southeastern Minnesota counties. PARTICIPANTS: Individuals (mean age 74, 54% male) with a first-ever HF code (International Classification of Diseases, Ninth Revision code 428 or Tenth Revision code I50) between January 1, 2013 and March 31, 2016 (N=2,692). MEASUREMENTS: Eight activities of daily living measured using a survey on a Likert scale (1=without any difficulty, 5=unable to do; median=8). Participants with a score greater than 8 were categorized as having functional limitation. Multimorbidity was defined as having 2 or more noncardiac comorbidities. RESULTS: Twenty-five percent of participants had neither multimorbidity nor functional limitation, 35% had multimorbidity, 9% had functional limitation, and 31% had both. After adjustment, participants with multimorbidity and functional limitation had greater risks of all outcomes (death: hazard ratio (HR)=4.92, 95% confidence interval (CI)=3.03-8.00; emergency department (ED) visit: HR=3.67, 95% CI=2.94-4.59; hospitalization: HR=3.66, 95% CI=2.85-4.70; outpatient visit: HR=1.73, 95% CI=1.52-1.96) than those with neither. Participants with functional limitation alone had greater risks of death (HR=4.84, 95% CI=2.78-8.43), ED visits (HR=2.35, 95% CI=1.75-3.16), and hospitalizations (HR=2.10, 95% CI=1.52-2.88) but not outpatient visits. Those with multimorbidity alone had similar risks of ED visits and hospitalizations as those with functional limitation alone but were more likely to have outpatient visits (HR=1.50, 95% CI=1.34-1.67). CONCLUSION: Individuals with both multimorbidity and functional limitation have the highest risk of death and healthcare use. Individuals with only functional limitation have similar rates of hospitalizations and ED visits as those with only multimorbidity, underscoring the need to consider both when managing individuals with HF.
OBJECTIVES: To characterize the individual and combined effects of multimorbidity and functional limitation on healthcare use and mortality in a large, community cohort of individuals with heart failure (HF). DESIGN: Prospective cohort study. SETTING: Eleven southeastern Minnesota counties. PARTICIPANTS: Individuals (mean age 74, 54% male) with a first-ever HF code (International Classification of Diseases, Ninth Revision code 428 or Tenth Revision code I50) between January 1, 2013 and March 31, 2016 (N=2,692). MEASUREMENTS: Eight activities of daily living measured using a survey on a Likert scale (1=without any difficulty, 5=unable to do; median=8). Participants with a score greater than 8 were categorized as having functional limitation. Multimorbidity was defined as having 2 or more noncardiac comorbidities. RESULTS: Twenty-five percent of participants had neither multimorbidity nor functional limitation, 35% had multimorbidity, 9% had functional limitation, and 31% had both. After adjustment, participants with multimorbidity and functional limitation had greater risks of all outcomes (death: hazard ratio (HR)=4.92, 95% confidence interval (CI)=3.03-8.00; emergency department (ED) visit: HR=3.67, 95% CI=2.94-4.59; hospitalization: HR=3.66, 95% CI=2.85-4.70; outpatient visit: HR=1.73, 95% CI=1.52-1.96) than those with neither. Participants with functional limitation alone had greater risks of death (HR=4.84, 95% CI=2.78-8.43), ED visits (HR=2.35, 95% CI=1.75-3.16), and hospitalizations (HR=2.10, 95% CI=1.52-2.88) but not outpatient visits. Those with multimorbidity alone had similar risks of ED visits and hospitalizations as those with functional limitation alone but were more likely to have outpatient visits (HR=1.50, 95% CI=1.34-1.67). CONCLUSION: Individuals with both multimorbidity and functional limitation have the highest risk of death and healthcare use. Individuals with only functional limitation have similar rates of hospitalizations and ED visits as those with only multimorbidity, underscoring the need to consider both when managing individuals with HF.
Authors: Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca Journal: Mayo Clin Proc Date: 2012-02 Impact factor: 7.616
Authors: Amy S Kelley; Kenneth E Covinsky; Rebecca J Gorges; Karen McKendrick; Evan Bollens-Lund; R Sean Morrison; Christine S Ritchie Journal: Health Serv Res Date: 2016-03-18 Impact factor: 3.402
Authors: Khalil Murad; David C Goff; Timothy M Morgan; Gregory L Burke; Traci M Bartz; Jorge R Kizer; Sarwat I Chaudhry; John S Gottdiener; Dalane W Kitzman Journal: JACC Heart Fail Date: 2015-07 Impact factor: 12.035
Authors: Susan L Hayes; Claudia A Salzberg; Douglas McCarthy; David C Radley; Melinda K Abrams; Tanya Shah; Gerard F Anderson Journal: Issue Brief (Commonw Fund) Date: 2016-08
Authors: Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña Journal: JAMA Date: 2009-04-08 Impact factor: 56.272
Authors: Jane S Saczynski; Alan S Go; David J Magid; David H Smith; David D McManus; Larry Allen; Jessica Ogarek; Robert J Goldberg; Jerry H Gurwitz Journal: J Am Geriatr Soc Date: 2013-01 Impact factor: 5.562
Authors: Sheila M Manemann; Alanna M Chamberlain; Cynthia M Boyd; Yariv Gerber; Shannon M Dunlay; Susan A Weston; Ruoxiang Jiang; Véronique L Roger Journal: J Am Geriatr Soc Date: 2016-06-27 Impact factor: 5.562
Authors: Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh Journal: Prev Chronic Dis Date: 2013-04-25 Impact factor: 2.830
Authors: Lindsey Anderson; Neil Oldridge; David R Thompson; Ann-Dorthe Zwisler; Karen Rees; Nicole Martin; Rod S Taylor Journal: J Am Coll Cardiol Date: 2016-01-05 Impact factor: 24.094
Authors: Mayra Tisminetzky; Jerry H Gurwitz; Dongjie Fan; Kristi Reynolds; David H Smith; Hassan Fouayzi; Sue Hee Sung; Robert Goldberg; Alan S Go Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-25 Impact factor: 6.053
Authors: Sheila M Manemann; David S Knopman; Jennifer St Sauver; Suzette J Bielinski; Alanna M Chamberlain; Susan A Weston; Ruoxiang Jiang; Véronique L Roger Journal: J Am Geriatr Soc Date: 2022-03-18 Impact factor: 7.538
Authors: A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni Journal: J Intern Med Date: 2018-11-22 Impact factor: 8.989
Authors: Sheila M Manemann; Jennifer St Sauver; Carrie Henning-Smith; Lila J Finney Rutten; Alanna M Chamberlain; Matteo Fabbri; Susan A Weston; Ruoxiang Jiang; Véronique L Roger Journal: J Am Heart Assoc Date: 2021-02-03 Impact factor: 6.106
Authors: Jorge Arias-de la Torre; Amy Ronaldson; Matthew Prina; Faith Matcham; Snehal M Pinto Pereira; Stephani L Hatch; David Armstrong; Andrew Pickles; Matthew Hotopf; Alex Dregan Journal: Lancet Healthy Longev Date: 2021-12
Authors: Alanna M Chamberlain; Lila J Finney Rutten; Debra J Jacobson; Chun Fan; Patrick M Wilson; Walter A Rocca; Véronique L Roger; Jennifer L St Sauver Journal: J Comorb Date: 2019-09-09